Akamai holder plans sale of 3,500 shares

A shareholder identified as Robert Blumofe has filed a notice of proposed sales of 3,500 shares of Akamai Technologies, Inc. common stock through broker Charles Schwab & Co., Inc., with an indicated aggregate market value of $339,500.00.

Accepted by SEC EDGAR 01/23/2026 - 10:40 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A shareholder identified as Robert Blumofe has filed a notice of proposed sales of 3,500 shares of Akamai Technologies, Inc. common stock through broker Charles Schwab & Co., Inc., with an indicated aggregate market value of $339,500.00. These shares relate to awards of performance and restricted stock units granted as equity compensation on 02/19/2025 and 02/21/2024, covering 1,887 and 1,613 shares respectively.

The planned sale is listed for an approximate date of 01/22/2026 on the NASDAQ, where Akamai’s common stock is traded. The form also shows that the same shareholder sold 3,500 shares for $301,000.00 on 11/07/2025 and 3,000 shares for $263,051.00 on 11/14/2025. Akamai had 143,865,237 shares of common stock outstanding as referenced in the notice.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for AKAM by Robert Blumofe disclose?

It discloses that shareholder Robert Blumofe plans to sell 3,500 shares of Akamai Technologies, Inc. common stock, with an indicated aggregate market value of $339,500.00, on the NASDAQ.

How many Akamai (AKAM) shares is the shareholder proposing to sell under this Form 144?

The notice covers a proposed sale of 3,500 shares of common stock of Akamai Technologies, Inc., to be sold through Charles Schwab & Co., Inc..

When is the planned sale date for the AKAM shares in this Form 144?

The filing lists an approximate date of sale of 01/22/2026 for the 3,500 shares of Akamai common stock to be sold on the NASDAQ.

How were the Akamai (AKAM) shares in this Form 144 acquired?

The shares were acquired as equity compensation via performance stock units (PSU) and PSU/RSU awards from Akamai Technologies, Inc. on 02/19/2025 for 1,887 shares and on 02/21/2024 for 1,613 shares.

What recent AKAM share sales by this person are disclosed in the Form 144?

The notice shows sales of 3,500 shares of Akamai securities for $301,000.00 on 11/07/2025 and 3,000 shares for $263,051.00 on 11/14/2025 by Robert Blumofe.

How many Akamai (AKAM) shares are outstanding according to this Form 144 notice?

The filing references 143,865,237 shares of Akamai Technologies, Inc. common stock outstanding in connection with the proposed sale.

On which exchange will the AKAM shares in this Form 144 be sold?

The Form 144 identifies the NASDAQ as the securities exchange where the 3,500 shares of Akamai common stock are proposed to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001576905
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AKAMAI TECHNOLOGIES INC
SEC File Number	000-27275
Address of Issuer	145 BROADWAY CAMBRIDGE MASSACHUSETTS 02142
Phone	6174443000
Name of Person for Whose Account the Securities are To Be Sold	Blumofe Robert
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	3500	339500.00	143865237	01/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/19/2025	PSU	Akamai Technologies, Inc.			1887	02/19/2025	Equity Compensation
Common	02/21/2024	PSU / RSU	Akamai Technologies, Inc.			1613	02/21/2024	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Robert Blumofe 145 BROADWAY CAMBRIDGE MA 02142	AKAMAI TECHNOLOGIES INC	11/07/2025	3500	301000.00
Robert Blumofe 145 BROADWAY CAMBRIDGE MA 02142	AKAMAI TECHNOLOGIES INC	11/14/2025	3000	263051.00

144: Remarks and Signature

Remarks	Late filing for 1/22/2026 trade due to Broker error.
Date of Notice	01/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Robert Blumofe
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)